Dexmedesed (dexmedetomidine hydrochloride) sterile injectable solution 0.5MG/ML and 2 more items

The University of Virginia awarded contract A207_PO-0474307 to WA Butler Company, doing business as Covetrus North America, LLC, on August 28, 2026. The contract, valued at $725, encompasses the delivery of pharmaceutical and medical supplies to Jeremy Gatesman. The primary deliverables include dexmedetomidine hydrochloride sterile injectable solution at 0.5 milligrams per milliliter (2 units at $74.98 each) and sodium chloride injection, USP preservative-free 0.9% in LifeShield plastic flip-top 10-milliliter containers (6 units at $95.29 each). These pharmaceutical products are commonly utilized in veterinary and medical settings for sedation and hydration purposes.

The contract award includes ancillary charges totaling $99.98 for the pharmaceutical supplies and one freight charge of $4.00. The cumulative contract value is $725. All deliverables are designated for delivery to Jeremy Gatesman at the University of Virginia location. This purchase order represents a routine procurement of injectable pharmaceuticals and related logistics services necessary for the University of Virginia's operational requirements.